KRD: Device, Vascular, For Promoting Embolization

Product code KRD, “Device, Vascular, For Promoting Embolization” in FDA's classification database, is a Class II device type under 21 CFR 870.3300 (vascular embolization device), reviewed by FDA's Cardiovascular panel. FDA's 510(k) database lists 133 clearances under KRD, 99 of them since 2011.
Updated Oct 29, 2026 · Clearances from FDA’s 510(k) database, as of Oct 29, 2026
Product code
KRD
Regulation
21 CFR 870.3300
Class
II
Panel
Cardiovascular
Clearances
133
Most recent
Oct 6, 2026
Median review, last 2 years
70 days
Third-party review
Not eligible
Implant
Yes

What it covers

A vascular embolization device is an intravascular implant intended to control hemorrhaging due to aneurysms, certain types of tumors (e.g., nephroma, hepatoma, uterine fibroids), and arteriovenous malformations. This does not include cyanoacrylates and other embolic agents, which act by polymerization or precipitation. Embolization devices used in neurovascular applications are also not included in this classification, see § 882.5950 of this chapter.

The identification in 21 CFR 870.3300, vascular embolization device. FDA gives KRD no definition of its own, so the regulation’s describes it.

FDA flags KRD devices as implants.

Recent clearances

510(k)DeviceApplicantDecisionType
K262798LOBO Vascular Occlusion SystemOkami Medical, Inc.Oct 6, 2026Traditional
K252812UniPearls® Embolic MicrospheresSuzhou Haowei Medical Technology Co., Ltd.Jul 31, 2026Traditional
K261488OBSIDIO Conformable EmbolicBoston Scientific CorporationJul 24, 2026Traditional
K261866Concerto Versa™ Detachable CoilMedtronic, Inc.Jun 24, 2026Special
K260635HARBOR Occlusion DeviceNuvascular, Inc.Jun 12, 2026Traditional
K260508LOBO Vascular Occlusion SystemOkami Medical, Inc.Apr 10, 2026Traditional
K253511Concerto Versa™ Detachable CoilMedtronic, Inc.Jan 14, 2026Traditional
K253677Tembo Embolic SystemInstylla, Inc.Dec 15, 2025Special
K253376OBSIDIO™ Conformable Embolic (M0013972101010)Boston Scientific CorporationOct 30, 2025Special
K250209Polyvinyl Alcohol Embolic MicrospheresCanyon Medical, Inc.Sep 23, 2025Traditional
From FDA’s 510(k) database, as of Oct 29, 2026Export CSV (100 rows free · all 133 with a free account)

Clearances by year

99 KRD 510(k)s were cleared from 2011 to Oct 29, 2026. Days to decision run from the day FDA received the 510(k) to its decision, including time on hold.

YearClearancesMedian days to decision
2026 (so far)770
2025960
2024670
20232137
20228175
20213134
20204137
20196178
2018462
2017489
20164164
201511130
20147134
20131133
2012830
2011536

Who submits

40 applicants cleared a KRD device since 2011. 80% of the clearances went to applicants in United States, then France (9%), China (5%) and United Kingdom (3%). By type: Traditional 67%, Special 32% and Abbreviated 1%.

ApplicantClearances since 2011
MicroVention, Inc.14
Biosphere Medical, S.A.9
Boston Scientific Corporation6
Cook Incorporated6
Boston Scientific Corp5
Vascular Solutions, Inc.5
Reverse Medical Corporation4
Artventive Medical Group, Inc.3

How FDA classifies it

Class II (special controls.) The special control for this device is the FDA guidance document entitled “Class II Special Controls Guidance Document: Vascular and Neurovascular Embolization Devices.” For availability of this guidance document, see § 870.1(e).

From 21 CFR 870.3300. Special controls are the requirements a 510(k) must show it meets.

Standards

21 CFR 870.3300 names no consensus standards. Check FDA’s recognized standards database, or ask which standards recent KRD clearances declared.

Ask about KRD

US FDA devices: 510(k), De Novo, guidance, 21 CFR

Questions about KRD

What is FDA product code KRD?

Product code KRD, “Device, Vascular, For Promoting Embolization” in FDA's classification database, is a Class II device type under 21 CFR 870.3300 (vascular embolization device), reviewed by FDA's Cardiovascular panel. FDA's 510(k) database lists 133 clearances under KRD, 99 of them since 2011.

How many 510(k) clearances are there under KRD?

FDA’s 510(k) database listed 133 clearances under KRD as of Oct 29, 2026, 99 of them decided since 2011; the most recent decision was Oct 6, 2026. The Predicate Finder searches the live database.

How long does FDA take to clear a KRD 510(k)?

For the 17 KRD clearances decided in the two years before Oct 29, 2026, the median time from FDA receiving the 510(k) to its decision was 70 days. That counts calendar days, including time the submission was on hold waiting for answers from the submitter.

Which companies have the most KRD clearances?

Since 2011: MicroVention, Inc. (14), Biosphere Medical, S.A. (9), Boston Scientific Corporation (6), Cook Incorporated (6) and Boston Scientific Corp (5). 40 applicants have cleared a KRD device in that time.

Sources

  1. FDA product classification: KRD · Product Classification database
  2. 21 CFR 870.3300: Vascular embolization device · eCFR, as of Oct 27, 2026
  3. openFDA 510(k) query for KRD · run Oct 29, 2026
  4. 510(k) Premarket Notification database · FDA, accessdata.fda.gov
Follow KRDGet an email when FDA clears, recalls or publishes guidance for KRD devices.

Know what FDA already cleared.